CDI Laboratories, Inc.

CDI Labs provides proteomic research services for autoantibody profiling, biomarker discovery, and target identification using platforms like the HuProt Human Proteome Microarray and PhIP-Seq technologies. The company serves pharmaceutical and research organizations working in autoimmune diseases, oncology, infectious diseases, and drug discovery.